ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.93% | 21.48% | 65.05% | 41.90% | 27.25% |
| Total Depreciation and Amortization | 41.58% | -4.67% | 6.59% | 1.72% | -0.45% |
| Total Amortization of Deferred Charges | -6.24% | -7.34% | -7.62% | -7.61% | -3.26% |
| Total Other Non-Cash Items | -27.73% | 383.90% | -57.59% | -13.62% | 131.32% |
| Change in Net Operating Assets | 2.86% | 224.10% | -163.72% | -519.52% | 190.69% |
| Cash from Operations | 22.42% | 43.93% | 13.12% | 13.71% | 85.36% |
| Capital Expenditure | -22.93% | 1.86% | 11.60% | 40.60% | 27.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -603.55% | 100.00% | 91.07% | -- | -1,192.45% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,935.84% | -23.73% | -49.52% | 226.80% | 81.70% |
| Cash from Investing | -187.50% | 4.12% | 10.82% | 101.44% | 0.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.33% | 100.00% | 96.15% | 83.78% | -106.90% |
| Issuance of Common Stock | 8.89% | 84.44% | 37.66% | 752.80% | 17.89% |
| Repurchase of Common Stock | -99.50% | -49.84% | -58.67% | -22,297.33% | -14,997.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.97% | -10.23% | -9.93% | -10.33% | -9.04% |
| Other Financing Activities | -- | -- | -- | 33.87% | 100.00% |
| Cash from Financing | 58.33% | 57.11% | 38.26% | 0.25% | -108.54% |
| Foreign Exchange rate Adjustments | 27,475.97% | 250.19% | -442.32% | 323.16% | 105.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61,261.20% | 1,384.90% | 8,233.30% | 1,100.48% | 15,133.33% |